Stockreport

ALX Oncology to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 [Yahoo! Finance]

ALX Oncology Holdings Inc.  (ALXO) 
PDF the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients' lives, today [Read more]